Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Triage and red flags
Immediate risk screen
Fever
Rapidly progressive erythema
Systemic toxicity
Immunocompromised state
Severe pain out of proportion
Inability to bear weight
Acute locked knee
Hot swollen knee with large effusion
Recent penetrating trauma or injection at site
If septic arthritis concern, immediate ED level evaluation
If necrotizing soft tissue infection concern, immediate surgical consult
Key concepts
Working diagnosis frame
Medial proximal tibial pain
Pain at pes anserinus insertion region
Overuse and biomechanical contributors
Common co-morbidity with knee osteoarthritis
Infection uncommon but high consequence
Monitoring targets
Reassessment checkpoints
Pain trend after initial analgesia
Weight bearing ability trend
Skin temperature and erythema trend
Range of motion limitation trend
If worsening despite conservative plan, diagnostic reassessment
History
Symptom pattern
Pain features
Medial knee pain location
Proximal medial tibial point tenderness
Activity related flare
Stair climbing related flare
Rising from chair related flare
Night pain
Mechanical symptoms
Instability symptoms
Timeline and triggers
Temporal context
Acute overuse change
New running or walking volume
New hills or stairs exposure
New footwear
Recent knee injury
Recent knee surgery
Risk factors and comorbidities
Predisposition
Knee osteoarthritis symptoms
Obesity
Diabetes mellitus
Pes planus
Valgus knee alignment symptoms
Hamstring tightness symptoms
Prior medial knee pathology
Infection risk history
Infectious clues
Fever or chills
Skin break near site
Cellulitis history
Immunosuppression
Recent injection
MRSA risk factors
Medication context
Medication factors
Anticoagulants
Antiplatelets
NSAID contraindications
Steroid injection glucose sensitivity
Allergy history
Physical Exam
Focused knee and pes region
Local findings
Point tenderness at anteromedial proximal tibia
Local swelling over pes region
Warmth or erythema
Pain with resisted knee flexion
Pain with resisted hip adduction
Hamstring tightness
Knee joint assessment
Joint evaluation
Effusion presence
Active range of motion
Passive range of motion
Pain with terminal flexion
Medial joint line tenderness
Patellofemoral pain provocation
Stability and meniscus screen
Co-injury screen
Valgus stress pain or laxity
Varus stress pain or laxity
Anterior drawer or Lachman laxity
McMurray pain or click
Thessaly pain
Neurovascular and skin
Distal status
Distal pulses
Distal sensation
Skin integrity near tenderness region
If cellulitis signs, margin tracking for progression
PITFALLS
Common misses
Medial meniscus tear mistaken for bursitis
Medial tibial stress injury mistaken for bursitis
Septic arthritis mistaken for bursitis when large effusion present
Referred pain from hip in older adults
Differential Diagnosis
Medial knee pain differential
Common mimics
Medial meniscus tear
Medial collateral ligament sprain
Knee osteoarthritis flare
Patellofemoral pain syndrome
Semimembranosus tendinopathy
Hamstring tendinopathy
Medial plica syndrome
High risk alternatives
Dangerous alternatives
Septic arthritis
Septic bursitis
Osteomyelitis
Necrotizing soft tissue infection
Deep vein thrombosis with atypical presentation
Imaging driven alternatives
Structural alternatives
Medial tibial plateau fracture
Medial tibial stress fracture
Osteochondral lesion
Meniscal root tear
Coding aligned problem list
ICD-10 and SNOMED mapping
Pes anserinus bursitis SNOMED CT 73105000
Other bursitis of knee ICD-10-CM M70.5 category
Right knee bursitis ICD-10-CM M70.51
Left knee bursitis ICD-10-CM M70.52
Laboratory Tests
When infection or systemic disease possible
Infection workup triggers
Fever
Marked warmth and erythema
Rapid progression
Immunocompromised state
Large effusion with limited range of motion
Severe pain and inability to bear weight
Post injection worsening
If septic arthritis concern, joint aspiration prioritized over serum markers
Serum tests
Supportive labs
Complete blood count for systemic infection concern
Leukocytosis supportive but non diagnostic
Normal count does not exclude infection
C reactive protein for inflammatory or infectious concern
Trend helpful for response
Single value limited specificity
Erythrocyte sedimentation rate for inflammatory or infectious concern
Slow kinetics
Limited specificity
Serum glucose for diabetes and steroid injection planning
Hyperglycemia risk counseling after injection
Fluid studies when aspirated
Aspiration analysis
Gram stain
Limited sensitivity
Positive supports infection
Culture and sensitivity
Highest yield for targeted therapy
Prior antibiotics reduce yield
Cell count with differential
High neutrophils support infection
Overlap with inflammatory states
Crystal analysis when gout or CPPD possible
Coexistence with infection possible
Diagnostic Tests
Scoring Systems
Decision aids and symptom scales
Ottawa Knee Rule for radiograph decision after acute injury
Age 55 years or older
Isolated patellar tenderness
Fibular head tenderness
Inability to flex to 90 degrees
Inability to bear weight 4 steps
Patient reported outcome tools for follow up
KOOS for knee function tracking
WOMAC for osteoarthritis symptom tracking
Radiographs
Plain film role
Normal in isolated bursitis typical
Osteoarthritis severity assessment
Fracture exclusion after trauma mechanism
Standard views when indicated
AP
Lateral
Sunrise or merchant for patellofemoral symptoms
Weight bearing views for osteoarthritis assessment
MRI
MRI indications
Persistent pain despite appropriate conservative care
Mechanical symptoms
Suspected meniscal tear
Suspected stress fracture when radiographs negative
Suspected occult tibial plateau fracture
Suspected tendon tear
Suspected osteochondral lesion
MRI interpretation pearls
Pes bursa fluid signal may be present
Concomitant degenerative changes common
CT
CT indications
Tibial plateau fracture characterization when suspected
Preoperative planning when fracture confirmed
Limited role for isolated bursitis
Ultrasound
Point of care and diagnostic ultrasound
Bursa fluid distension evaluation
Guidance for aspiration or injection
Cellulitis versus fluid collection differentiation
Doppler evaluation for hyperemia supportive of inflammation
DVT ultrasound if clinical suspicion for calf swelling and risk factors
Disposition
Outpatient management
Discharge appropriate
Stable vitals
No systemic infection features
No large effusion with severe range limitation
Pain controlled with oral plan
Ambulation feasible with or without aid
Clear follow up plan
Referral and follow up timing
Follow up targets
Primary care or sports medicine in 1 to 2 weeks if persistent symptoms
Physical therapy referral early when biomechanical contributors present
Orthopedics referral if refractory or structural pathology suspected
Escalation and admission criteria
Higher level care triggers
Septic arthritis concern
Rapidly progressive cellulitis
Immunocompromised with systemic symptoms
Inability to bear weight with concerning exam
Suspected fracture despite negative radiographs
Treatment
Immediate life-saving interventions
Infection and sepsis pathways
If septic arthritis concern, emergent joint aspiration and orthopedic consult
If unstable or septic, IV antibiotics after cultures
If stable, antibiotics after aspiration when feasible
If necrotizing infection concern, immediate surgical consult and broad spectrum antibiotics
Immobilization and Splinting
Activity modification supports
Relative rest from provoking activity
Temporary reduction of stairs and hills
Short term cane on contralateral side for painful gait
Knee sleeve for comfort if helpful
Reduction
Not applicable for isolated bursitis
If mechanical locking or instability, alternate diagnosis pathway
If acute trauma deformity, fracture or dislocation pathway
Open fracture medications and timing
Not applicable for isolated bursitis
If open wound near knee after trauma, open injury pathway
DVT prophylaxis when relevant
Not routinely indicated
If prolonged immobility from pain, individual risk assessment
If suspected DVT, diagnostic pathway rather than prophylaxis
Conservative care
First line measures
Ice packs 10 to 15 minutes
Up to 3 to 5 times daily
Skin barrier to prevent frost injury
Compression as tolerated
Avoid excessive tightness
Stop if paresthesia or color change
Elevation when swollen
Above heart level when feasible
Short frequent sessions
Topical NSAID option
Diclofenac 1 percent gel
2 g to knee region up to 4 times daily
Oral NSAID options when no contraindication
Ibuprofen 400 mg every 6 to 8 hours as needed
Naproxen 250 to 500 mg twice daily as needed
Avoid duplicate NSAIDs
Acetaminophen options
500 to 1000 mg every 6 to 8 hours as needed
Maximum daily limit per local policy and liver risk
Physical therapy and biomechanics
Rehab focus
Hamstring stretching program
Quadriceps strengthening
Hip abductor strengthening
Core stabilization
Gait retraining if valgus collapse
Gradual return to run or walk program
Mechanical contributors
Foot orthoses for pes planus symptoms
Shoe assessment and replacement if worn
Weight management counseling when appropriate
Injection and procedures
Indications for injection
Persistent pain despite conservative therapy
Functional limitation despite rehab
Localized tenderness with supportive ultrasound findings
Corticosteroid injection principles
Ultrasound guidance preferred when available
Avoid injection through cellulitis
Avoid if bacteremia concern
Limit repeat injections
Minimum 3 months between injections
Typical maximum 3 to 4 per year per site
Example injection regimen
Triamcinolone acetonide 20 to 40 mg
With lidocaine 1 percent 1 to 2 mL
Total volume tailored to anatomy
Post injection rest 24 to 48 hours
Post injection counseling
Post injection flare 24 to 72 hours possible
Skin atrophy or hypopigmentation risk
Infection risk low but present
Transient hyperglycemia risk in diabetes
Antibiotics when septic bursitis suspected
Outpatient oral options when stable and no joint involvement
Cephalexin 500 mg four times daily
Typical duration 7 to 10 days
Adjust for renal function
If MRSA risk, trimethoprim sulfamethoxazole DS 1 tablet twice daily
Combine with beta lactam if streptococcal coverage needed
If beta lactam allergy, clindamycin 300 to 450 mg three times daily
C difficile risk counseling
IV antibiotics and admission triggers
Systemic toxicity
Immunocompromised state
Failure of oral therapy
Concern for septic arthritis or deep infection
Special Populations
Pregnancy
Pregnancy considerations
Prefer non pharmacologic measures first
Acetaminophen preferred analgesic when needed
NSAID avoidance in later pregnancy
Injection risk benefit individualized
Ultrasound favored imaging modality
Geriatric
Older adult considerations
High prevalence coexisting osteoarthritis
Lower threshold for radiographs after trauma
NSAID renal and GI risk
Fall risk with painful gait
Assistive device planning
Pediatrics
Pediatric considerations
Less common diagnosis than in adults
Growth plate injury as alternative diagnosis after trauma
Septic arthritis vigilance with fever and refusal to bear weight
Weight based analgesic dosing
Ibuprofen 10 mg per kg per dose every 6 to 8 hours
Maximum single dose per local policy
Acetaminophen 15 mg per kg per dose every 4 to 6 hours
Background
Epidemiology
Epidemiology essentials
Common cause of medial knee pain syndrome in adults
Association with obesity and knee osteoarthritis
Association with overuse and biomechanical stress
Pathophysiology
Mechanism
Bursa inflammation between pes tendons and medial tibia
Microtrauma from repetitive friction
Contributing tendinopathy common
Adjacent osteoarthritis increases local stress and pain sensitization
Therapeutic Considerations
Treatment rationale
Load reduction decreases friction and inflammation
Stretching reduces pes tendon tension
Strengthening improves knee and hip mechanics
Topical NSAIDs reduce local inflammation with lower systemic risk
Steroid injection for refractory cases to reduce inflammatory cascade
Evidence framing
Conservative care as first line standard
Corticosteroid injection effective for short term pain relief in some studies
Long term outcomes linked to addressing biomechanics and comorbid OA
Patient Discharge Instructions
copy discharge instructions
Home plan
Relative rest from stairs hills squats and running
Ice 10 to 15 minutes up to 3 to 5 times daily
Topical diclofenac option if safe
Oral ibuprofen or naproxen option if safe
Acetaminophen option if needed
Gentle hamstring stretching daily
Gradual return to activity only when improving
Follow up
Primary care or sports medicine in 1 to 2 weeks if not improving
Physical therapy referral for strengthening and stretching program
Imaging discussion if persistent pain beyond 4 to 6 weeks
Return now or urgent reassessment
Fever
Rapidly spreading redness
Hot swollen knee with severe motion pain
Inability to bear weight
New numbness or foot weakness
New calf swelling or shortness of breath
Worsening pain despite rest and medication
References
Clinical summaries and reviews
Reference set
StatPearls Pes Anserine Bursitis updated 2024
Gouda et al comparative efficacy corticosteroid injection versus PRP versus ESWT 2023
AJR review local and systemic side effects of corticosteroid injections 2024
MedlinePlus steroid injections risks updated 2024
Coding and terminology
Coding references
ICD-10-CM M70.51 other bursitis of knee right knee
ICD-10-CM M70.52 other bursitis of knee left knee
SNOMED CT 73105000 pes anserinus bursitis
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.